pamidronate

Known as: aminopropanehydroxydiphosphonate, pamidronate [Chemical/Ingredient], amino-1-hydroxypropane-1,1-diphosphonate 
A synthetic bisphosphonate agent. Although its mechanism of action is not completely understood, pamidronate appears to adsorb to calcium phosphate… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Objective: To determine if blood neurofilament light chain (NfL) protein can discriminate between Parkinson disease (PD) and… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2001
Highly Cited
2001
PURPOSE Zoledronic acid, a new and more potent bisphosphonate, was compared with pamidronate, the current standard treatment for… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Collapsing focal segmental glomerulosclerosis (FSGS) is a distinct clinicopathologic entity seen most commonly in young African… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND Treatment with a gonadotropin-releasing hormone agonist decreases bone mineral density and increases the risk of… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
PURPOSE Two identical, concurrent, parallel, multicenter, randomized, double-blind, double-dummy trials were conducted to compare… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
PURPOSE To assess whether pamidronate can reduce the frequency of skeletal morbidity in women with lytic bone metastases from… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
BACKGROUND Severe osteogenesis imperfecta is a disorder characterized by osteopenia, frequent fractures, progressive deformity… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
PURPOSE Pamidronate, an aminobisphosphonate, has been shown to lower the risk of skeletal complications associated with lytic… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
PURPOSE To determine the efficacy and safety of 21 monthly cycles of pamidronate therapy in patients with advanced multiple… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
BACKGROUND Skeletal complications are a major clinical manifestation of multiple myeloma. These complications are caused by… (More)
Is this relevant?